Revolutions Medical (RMCP) 0.0210 $RMCP
Bridge Bancorp, Inc. Announces Regulatory Approvals to Acquire FNBNY Bancorp; FNBNY Shareholder Meeting Date Set
GlobeNewswire - Tue Jan 14, 4:33PM CST
Bridge Bancorp, Inc. (Nasdaq:BDGE), the parent company of The Bridgehampton National Bank (BNB), announced today all regulatory approvals have been received in connection with the acquisition of FNBNY Bancorp and its wholly owned subsidiary, the First National Bank of New York (collectively "FNBNY"). In addition, FNBNY will hold a special meeting of shareholders on February 12, 2014 to obtain shareholder approval of the acquisition. Shareholders representing a majority of the FNBNY voting shares previously have entered into voting agreements to approve the acquisition, and the transaction is expected to close on Friday, February 14, 2014.
Global Disposable Syringe Market Report 2013
M2 - Fri Nov 29, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/lftm5m/disposable) has announced the addition of the "Global Disposable Syringe Market Report 2013" report to their offering. This study specifically focuses on market dynamics, current market drivers and emerging trends within the disposable syringe markets. Additionally, this review examines industry challenges and potential threats to syringe and needle supply manufacturers. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the public for medically-related uses. The market segments for disposable syringes are: - Prefilled syringes. - Safety syringes. - Insulin injector pens. - Needleless injectors. - Vaccination injectors. - Blood collection needles and syringes. - Hypodermic needles and syringes. - Insulin needles and syringes. - Specialty needles and syringes. Key Topics Covered: 1. Introduction 2. Syringe Types: An Overview 3. Award Winning Syringes 4. Syringe Industry: Overview 4.1 Common Diseases Transmitted by Unsafe Needle Use and Needlesticks 4.2 Most Common Instances of Needlestick Injuries 4.3 Needle Phobia and Patients' Anxieties 4.4 Global Transition to Safety Medical Devices 4.5 U.S. Regulation 4.6 Worldwide Regulation 4.7 Enforcing Compliance with Sharps Safety Legislation 4.8 Example of an OSHA Violation 4.9 Target Market Awaiting Premium Products 4.10 Current Types of Safety Syringes 4.11 Need for Safety Syringe Products 4.12 Limitations of Existing Clinical Syringes 4.13 Limitations of Existing Prefilled Syringes 4.14 Market Expansion for Safety Syringes 4.15 Technological Advancements in Disposable Syringes 4.16 Reconstitution inside Sterile Syringes 4.16.1 Vetter Lyo-Ject 4.17 Plungerless Prefilled Syringes 4.18 The Disposable UniJect 4.19 Needle-Free Injection 5. Disposable Syringes: Market Analysis 6. Company Profiles Companies Mentioned - Abbott Laboratories - Baxter International - Braun - Covidien - Henke-Sass - Hi-Tech Medical Products - Hindustan Syringes & - Hyaluron Contract Manufacturing - International Medication System - Life-Shield Products - MedPro Safety Products - Novo Nordisk - Plas-Pak Industries - Retractable Technologies - Revolutions Medical Corporation - Safety Syringes - Smiths Medical International/Medex - Star Syringe - Terumo Medical Corporation - UltiMed - Unilife Medical Solutions - Vetter Pharma-Fertigung GmbH & Co. - Vita Needle Company - West Pharmaceutical Services - Wuxi Yushou Medical Appliances - Ypsomed Holding - For more information visit http://www.researchandmarkets.com/research/lftm5m/disposable
BUYINS.NET Updates Revolutions Medical Corp. SqueezeTrigger Report
M2 - Wed Oct 16, 7:54AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on Revolutions Medical Corp (OTC: RMCP) after releasing the latest short sale data through October 15, 2013. The total aggregate number of shares shorted since August 2009 is approximately 34 million shares. Approximately 31.00% of daily trading volume is short selling. The SqueezeTrigger price for all RMCP shares shorted is $0.41. 3.13 million shares have been shorted below $0.05 and will begin squeezing when RMCP exceeds $0.05.
BUYINS.NET Issues Revolutions Medical Corp. SqueezeTrigger Report
M2 - Mon Jul 29, 9:57AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Revolutions Medical Corp (OTC: RMCP) after releasing the latest short sale data through July 26, 2013. The total aggregate number of shares shorted since August 2009 is approximately 31 million shares. Approximately 30.40% of daily trading volume is short selling. The SqueezeTrigger price for all RMCP shares shorted is $0.45. 928,000 shares have been shorted below $0.06 and have already begun squeezing.
$20 Million Awarded in Internet Libel Case
Marketwire - Mon Jul 01, 9:57AM CDT
Revolutions Medical Corporation (OTCQB: RMCP), a Charleston, S.C.-based medical device and software applications company, and its Chief Executive Officer, Rondald Wheet, have been awarded more than $20 million in a default judgment against Phillip Maurice "Marty" Hicks. A special referee for the South Carolina court awarded the company $3.6 million in compensatory damages and $1.5 million in punitive damages. Wheet was awarded $12,010,000 in compensatory damages and $3 million in punitive damages.
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
Revolutions Medical awarded 12m RevVac safety syringes order in Brazil
M2 - Wed May 22, 8:19AM CDT
Medical device company Revolutions Medical Corporation (OTC Markets:RMCP) reported on Tuesday the receipt of a 12m unit contract of its RevVac auto-retractable vacuum safety syringe in Brazil.
Revolutions Medical Receives Contract for 12 Million RevVac(TM) Safety Syringes From Its Brazilian Distributor
Marketwire - Tue May 21, 7:59AM CDT
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB: RMCP) has received a 12 million unit contract of its RevVacâ?¢ auto-retractable vacuum safety syringe from AGN Tech International, LLC, ("AGN Tech") the exclusive distributor of all RevVacâ?¢ safety syringe product lines in Brazil. The contract is for 1 million units per month for a twelve month term.
Revolutions Medical Wins $770,000 Arbitration Award for Fraud and Other Claims Against Former Manufacturer MIG and Former Consultant Richard Theriault
Marketwire - Thu Jan 03, 2:53PM CST
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB: RMCP) has prevailed in its case before the American Arbitration Association (AAA) against former manufacturer Medical Investment Group, Inc. (MIG) and former consultant Richard Theriault. AAA awarded the Company $770,000, in addition to interest, legal fees, and other arbitration costs, which will total close to $1 million dollars. MIG and its alter ego, Mr. Theriault, were found to have committed fraud in the inducement and breach of contract. Further, AAA found that neither MIG nor Mr. Theriault has any rights to any of the Company's intellectual property, proprietary information, trademarks, production equipment or designs related to the issues arbitrated in such proceeding.
Bridge Bancorp, Inc. Announces Regulatory Approvals to Acquire FNBNY Bancorp; FNBNY Shareholder Meeting Date Set
GlobeNewswire - Tue Jan 14, 4:33PM CST
Bridge Bancorp, Inc. (Nasdaq:BDGE), the parent company of The Bridgehampton National Bank (BNB), announced today all regulatory approvals have been received in connection with the acquisition of FNBNY Bancorp and its wholly owned subsidiary, the First National Bank of New York (collectively "FNBNY"). In addition, FNBNY will hold a special meeting of shareholders on February 12, 2014 to obtain shareholder approval of the acquisition. Shareholders representing a majority of the FNBNY voting shares previously have entered into voting agreements to approve the acquisition, and the transaction is expected to close on Friday, February 14, 2014.
Global Disposable Syringe Market Report 2013
M2 - Fri Nov 29, 6:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/lftm5m/disposable) has announced the addition of the "Global Disposable Syringe Market Report 2013" report to their offering. This study specifically focuses on market dynamics, current market drivers and emerging trends within the disposable syringe markets. Additionally, this review examines industry challenges and potential threats to syringe and needle supply manufacturers. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the public for medically-related uses. The market segments for disposable syringes are: - Prefilled syringes. - Safety syringes. - Insulin injector pens. - Needleless injectors. - Vaccination injectors. - Blood collection needles and syringes. - Hypodermic needles and syringes. - Insulin needles and syringes. - Specialty needles and syringes. Key Topics Covered: 1. Introduction 2. Syringe Types: An Overview 3. Award Winning Syringes 4. Syringe Industry: Overview 4.1 Common Diseases Transmitted by Unsafe Needle Use and Needlesticks 4.2 Most Common Instances of Needlestick Injuries 4.3 Needle Phobia and Patients' Anxieties 4.4 Global Transition to Safety Medical Devices 4.5 U.S. Regulation 4.6 Worldwide Regulation 4.7 Enforcing Compliance with Sharps Safety Legislation 4.8 Example of an OSHA Violation 4.9 Target Market Awaiting Premium Products 4.10 Current Types of Safety Syringes 4.11 Need for Safety Syringe Products 4.12 Limitations of Existing Clinical Syringes 4.13 Limitations of Existing Prefilled Syringes 4.14 Market Expansion for Safety Syringes 4.15 Technological Advancements in Disposable Syringes 4.16 Reconstitution inside Sterile Syringes 4.16.1 Vetter Lyo-Ject 4.17 Plungerless Prefilled Syringes 4.18 The Disposable UniJect 4.19 Needle-Free Injection 5. Disposable Syringes: Market Analysis 6. Company Profiles Companies Mentioned - Abbott Laboratories - Baxter International - Braun - Covidien - Henke-Sass - Hi-Tech Medical Products - Hindustan Syringes & - Hyaluron Contract Manufacturing - International Medication System - Life-Shield Products - MedPro Safety Products - Novo Nordisk - Plas-Pak Industries - Retractable Technologies - Revolutions Medical Corporation - Safety Syringes - Smiths Medical International/Medex - Star Syringe - Terumo Medical Corporation - UltiMed - Unilife Medical Solutions - Vetter Pharma-Fertigung GmbH & Co. - Vita Needle Company - West Pharmaceutical Services - Wuxi Yushou Medical Appliances - Ypsomed Holding - For more information visit http://www.researchandmarkets.com/research/lftm5m/disposable
BUYINS.NET Updates Revolutions Medical Corp. SqueezeTrigger Report
M2 - Wed Oct 16, 7:54AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on Revolutions Medical Corp (OTC: RMCP) after releasing the latest short sale data through October 15, 2013. The total aggregate number of shares shorted since August 2009 is approximately 34 million shares. Approximately 31.00% of daily trading volume is short selling. The SqueezeTrigger price for all RMCP shares shorted is $0.41. 3.13 million shares have been shorted below $0.05 and will begin squeezing when RMCP exceeds $0.05.
BUYINS.NET Issues Revolutions Medical Corp. SqueezeTrigger Report
M2 - Mon Jul 29, 9:57AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Revolutions Medical Corp (OTC: RMCP) after releasing the latest short sale data through July 26, 2013. The total aggregate number of shares shorted since August 2009 is approximately 31 million shares. Approximately 30.40% of daily trading volume is short selling. The SqueezeTrigger price for all RMCP shares shorted is $0.45. 928,000 shares have been shorted below $0.06 and have already begun squeezing.
$20 Million Awarded in Internet Libel Case
Marketwire - Mon Jul 01, 9:57AM CDT
Revolutions Medical Corporation (OTCQB: RMCP), a Charleston, S.C.-based medical device and software applications company, and its Chief Executive Officer, Rondald Wheet, have been awarded more than $20 million in a default judgment against Phillip Maurice "Marty" Hicks. A special referee for the South Carolina court awarded the company $3.6 million in compensatory damages and $1.5 million in punitive damages. Wheet was awarded $12,010,000 in compensatory damages and $3 million in punitive damages.
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
Revolutions Medical awarded 12m RevVac safety syringes order in Brazil
M2 - Wed May 22, 8:19AM CDT
Medical device company Revolutions Medical Corporation (OTC Markets:RMCP) reported on Tuesday the receipt of a 12m unit contract of its RevVac auto-retractable vacuum safety syringe in Brazil.
Revolutions Medical Receives Contract for 12 Million RevVac(TM) Safety Syringes From Its Brazilian Distributor
Marketwire - Tue May 21, 7:59AM CDT
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB: RMCP) has received a 12 million unit contract of its RevVacâ?¢ auto-retractable vacuum safety syringe from AGN Tech International, LLC, ("AGN Tech") the exclusive distributor of all RevVacâ?¢ safety syringe product lines in Brazil. The contract is for 1 million units per month for a twelve month term.
Revolutions Medical Wins $770,000 Arbitration Award for Fraud and Other Claims Against Former Manufacturer MIG and Former Consultant Richard Theriault
Marketwire - Thu Jan 03, 2:53PM CST
Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB: RMCP) has prevailed in its case before the American Arbitration Association (AAA) against former manufacturer Medical Investment Group, Inc. (MIG) and former consultant Richard Theriault. AAA awarded the Company $770,000, in addition to interest, legal fees, and other arbitration costs, which will total close to $1 million dollars. MIG and its alter ego, Mr. Theriault, were found to have committed fraud in the inducement and breach of contract. Further, AAA found that neither MIG nor Mr. Theriault has any rights to any of the Company's intellectual property, proprietary information, trademarks, production equipment or designs related to the issues arbitrated in such proceeding.
